The Effect of Finasteride on the Secretion of Testosterone, DHT, LH, FSH and Tissue Factors in the Testis of NMRI Mice Finasteride and Testosterone, DHT, LH, FSH
Archives of Advances in Biosciences,
Vol. 12 No. 2 (2021),
9 May 2021
,
Page 28-39
https://doi.org/10.22037/aab.v12i2.34834
Abstract
Introduction: The aim of this study was to investigate the effect of finasteride on spermatogenesis and male fertility. To do so, the effects of finasteride were examined for hormonal assays and testicular tissue changes.
Materials and Methods: This study was performed on male NMRI mice in five groups, namely control, sham, and three experimental groups that received finasteride (1, 5, and 20 mg/kg BW) for 35 days.
Results: As for hormonal observations, significant reductions of DHT in all injectable doses were recorded. Yet, testosterone only increased significantly in two doses of 5 and 20 mg/kg BW. Moreover, two hormones of FSH and LH were significantly reduced in the drug-receiving groups. In the view of histological findings, sperm count and motility were markedly different between the doses of 5 and 20 mg/kg BW in the epididymis. The frequency of primary spermatocytes, spermatids, and spermatozoids was considerably decreased in groups receiving finasteride at doses of 5 and 20 mg/kg BW. However, this happened only at a dose of 20 mg/kg BW for spermatogonial cells.
Conclusions: It is predicted that finasteride at a dose of 5 mg/kg BW and more can have side effects on male reproductive ability and spermatogenesis.
- Finasteride; Spermatogenesis; Hormone; Tissue; Testis
How to Cite
References
Stukenborg JB, Schlatt S, Simoni M, Yeung CH, Elhija MA, Luetjens CM, Huleihel M, Wistuba J. New horizons for in vitro spermatogenesis? An update on novel three-dimensional culture systems as tools for meiotic and post-meiotic differentiation of testicular germ cells. Molecular human reproduction. 2009 Sep 1;15(9):521-9.
Yamana K, Labrie F. Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride. Hormone molecular biology and clinical investigation. 2010 Aug 1;2(3):293-9.
Mysore V, Shashikumar BM. Guidelines on the use of finasteride in androgenetic alopecia. Indian Journal of Dermatology, Venereology, and Leprology. 2016 Mar 1;82(2):128.
Amory JK, Anawalt BD, Matsumoto AM, Page ST, Bremner WJ, Wang C, Swerdloff RS, Clark RV. The effect of 5α-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men. The Journal of urology. 2008 Jun;179(6):2333-8.
Tu HY, Zini A. Finasteride-induced secondary infertility associated with sperm DNA damage. Fertility and sterility. 2011 May 1;95(6):2125-e13.
Kang HJ, Imperato-McGinley J, Zhu YS, Rosenwaks Z. The effect of 5α-reductase-2 deficiency on human fertility. Fertility and sterility. 2014 Feb 1;101(2):310-6.
Fertig R, Shapiro J, Bergfeld W, Tosti A. Investigation of the plausibility of 5-alpha-reductase inhibitor syndrome. Skin appendage disorders. 2016;2(3-4):120-9.
Mohebali S, Roodbari NH, Hajihosseini R, Parivar K. The effects of Finasteride on the expression of Dazl, Tsga10, Sycp3, Prm2 genes during spermatogenesis in testes of NMRI mice. European Review for Medical and Pharmacological Sciences. 2020 Aug 1;24(15):8160-3.
Mohebali S, Nasri S, Asghari S, Karimi Dehbehi F, Heydarizad M, Kordestani F, Darzi F, Mohammad Najar S. Antinociceptive and Anti-Inflammatory Effects of Matricaria Chamomilla L. in Male Mice. Complementary Medicine Journal. 2013 Sep 10;3(2):451-61.
Mirela M, Ioana P, Maria PG, Mihnea MC. Finasteride side effects and post-Finasteride syndrome in male androgenic alopecia. Journal of Mind and Medical Sciences. 2015;2(2):142-9.
Ray D, Pitts PB, Hogarth CA, Whitmore LS, Griswold MD, Ye P. Computer simulations of the mouse spermatogenic cycle. Biology open. 2014 Dec 12;4(1):1-2.
Hemayatkhah Jahromi V, Parivar K, Forozanfar M. The effect of cinnamon extract on spermatogenesis hormonal axis of pituitary gonad in mice. Iranian Journal of Applied Animal Science. 2011 Jun 1;1(2):99-103.
Mirhoseini M, Mohamadpour M, Khorsandi L. Toxic effects of Carthamus tinctorius L. (Safflower) extract on mouse spermatogenesis. Journal of assisted reproduction and genetics. 2012 May;29(5):457-61.
Steiner JF. Clinical pharmacokinetics and pharmacodynamics of finasteride. Clinical pharmacokinetics. 1996 Jan;30(1):16-27.
McCabe MJ, Allan CM, Foo CF, Nicholls PK, McTavish KJ, Stanton PG. Androgen initiates Sertoli cell tight junction formation in the hypogonadal (hpg) mouse. Biology of reproduction. 2012 Aug 1;87(2):38-1.
Garcia PV, Barbieri MF, Perobelli JE, Consonni SR, Mesquita SD, de Grava Kempinas W, Pereira LA. Morphometric-stereological and functional epididymal alterations and a decrease in fertility in rats treated with finasteride and after a 30-day post-treatment recovery period. Fertility and sterility. 2012 Jun 1;97(6):1444-51.
McLachlan RI, O'Donnell L, Meachem SJ, Stanton PG, De Kretser DM, Pratis K, Robertson DM. Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. Recent progress in hormone research. 2002 Jan 1;57(1):149-79.
Rhoden EL, Gobbi D, Menti E, Rhoden C, Telöken C. Effects of the chronic use of finasteride on testicular weight and spermatogenesis in Wistar rats. BJU international. 2002 Jun;89(9):961-3..
Pole M, Koren G. Finasteride. Does it affect spermatogenesis and pregnancy?. Canadian family physician. 2001 Dec 1;47(12):2469-70.
Overstreet JW, Fuh VL, Gould J, Howards SS, Lieber MM, Hellstrom W, Shapiro S, Carroll P, Corfman RS, Petrou S, LEWIS R. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. The Journal of urology. 1999 Oct 1;162(4):1295-300.
Petroni A, Cappa M, Blasevich M, Solinas M, Uziel G. New findings on X-linked Adrenoleukodystrophy: 5α-reductase isoform 2 relative gene expression is modified in affected fibroblasts. Neuroscience letters. 2004 Sep 9;367(3):269-72.
Robaire B, Henderson NA. Actions of 5α-reductase inhibitors on the epididymis. Molecular and Cellular Endocrinology. 2006 May 16;250(1-2):190-5.
Hejmej A, Bilinska B. The effects of flutamide on cell-cell junctions in the testis, epididymis, and prostate. Reproductive Toxicology. 2018 Oct 1;81:1-6.
Uygur MC, Arık Aİ, Altuğ U, Erol D. Effects of the 5α-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study. Steroids. 1998 Apr 1;63(4):208-13.
Amory JK, Wang C, Swerdloff RS, Anawalt BD, Matsumoto AM, Bremner WJ, Walker SE, Haberer LJ, Clark RV. The effect of 5α-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. The Journal of Clinical Endocrinology & Metabolism. 2007 May 1;92(5):1659-65.
Gundersen TD, Jørgensen N, Andersson AM, Bang AK, Nordkap L, Skakkebæk NE, Priskorn L, Juul A, Jensen TK. Association between use of marijuana and male reproductive hormones and semen quality: a study among 1,215 healthy young men. American journal of epidemiology. 2015 Sep 15;182(6):473-81.
Castro‐Magana Ma, Angulo M, Fuentes B, Canas A, Sarrantonio M, Arguello R, Vitollo P. Effect of finasteride on human testicular steroidogenesis. Journal of andrology. 1996 Sep 10;17(5):516-21.
Amory JK, Wang C, Swerdloff RS, Anawalt BD, Matsumoto AM, Bremner WJ, Walker SE, Haberer LJ, Clark RV. The effect of 5α-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. The Journal of Clinical Endocrinology & Metabolism. 2007 May 1;92(5):1659-65.
Na GJ, Hwang IS, Oh KJ, Kim KW, Kang TW, Kwon DD, Park KS, Ryu SB, Park YI. The Effects of Finasteride on Pituitary-Testicular Hormone Axis and Spermatogenesis in Rat. Chonnam Medical Journal. 2005 Apr 1;41(1):72-81.
Vanderstichele H, Eechaute W, Lacroix E. Regulation of the pituitary 5α-reductase activity by gonadotropin releasing hormone and testosterone in the adult male rat. Journal of steroid biochemistry. 1990 Apr 1;35(5):575-81.
Nagamoto A, Noguchi K, Murai T, Kinoshita Y. Significant role of 5α‐reductase on feedback effects of androgen in rat anterior pituitary cells demonstrated with a nonsteroidal 5α‐reductase inhibitor ONO‐3805. Journal of andrology. 1994 Nov 12;15(6):521-7.
Prahalada S, Majka JA, Soper KA, Nett TM, Bagdon WJ, Peter CP, Burek JD, MacDonald JS, Van Zwieten MJ. Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5α-reductase inhibitor: a possible mechanism. Fundamental and Applied Toxicology. 1994 Feb 1;22(2):211-9.
Castelli MP, Casti A, Casu A, Frau R, Bortolato M, Spiga S, Ennas MG. Regional distribution of 5α-reductase type 2 in the adult rat brain: an immunohistochemical analysis. Psychoneuroendocrinology. 2013 Feb 1;38(2):281-93.
Mukai Y, Higashi T, Nagura Y, Shimada K. Studies on neurosteroids XXV. Influence of a 5α-reductase inhibitor, finasteride, on rat brain neurosteroid levels and metabolism. Biological and Pharmaceutical Bulletin. 2008 Sep 1;31(9):1646-50.
Giatti S, Diviccaro S, Falvo E, Garcia-Segura LM, Melcangi RC. Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites. Frontiers in neuroendocrinology. 2020 Apr 1;57:100836.
Robitaille J, Langlois VS. Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates. General and comparative endocrinology. 2020 May 1;290:113400.
- Abstract Viewed: 575 times
- PDF Downloaded: 169 times